{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-267053","form_type":"8-K","ticker":"IQV","cik":"0001478242","company_name":"IQVIA HOLDINGS INC.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.492280+00:00","generated_at":"2026-05-17T00:14:58.283097+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board","bullets":["Appointment effective November 5, 2025.","Kaelin awarded 2019 Nobel Prize in Physiology or Medicine for oxygen-sensing and VHL tumor suppressor work.","Senior physician-scientist at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School.","Also serves on Eli Lilly board and chairs its Science and Technology Committee.","Board determined Kaelin meets NYSE independence standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-267053","json":"https://secwatch.observer/filing/0001193125-25-267053.json","markdown":"https://secwatch.observer/filing/0001193125-25-267053.md","text":"https://secwatch.observer/filing/0001193125-25-267053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478242/000119312525267053/0001193125-25-267053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478242/000119312525267053/d89736d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:14:58.283097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}